A Prospective Study Comparing the Success Rate of Injection of (DefluxR) Versus (VantrisR) for VUR in Children

NCT02271035 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Vesico-Ureteral Reflux

Interventions

DRUG: Deflux
DRUG: Vantris

Sponsor

Rabin Medical Center